Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021

被引:8
|
作者
Yang, Hong [1 ]
Qi, Qi [2 ]
Zhang, Yong [3 ]
Wen, Ning [1 ]
Cao, Lei [1 ]
Liu, Yu [2 ]
Fan, Chunxiang [1 ]
Yan, Dongmei [3 ]
Zhu, Xiaoping [2 ]
Hao, Lixin [1 ]
Zhu, Shuangli [3 ]
Ma, Qianli [2 ]
Liu, Jiajie [2 ]
Ma, Chao [1 ]
Nan, Lei [4 ]
Chen, Yong [5 ]
Ma, Xiaozhen [2 ]
Chen, Na [2 ]
Deng, Kun [4 ]
Shao, Ge [6 ]
Ding, Xianxiang [6 ]
An, Zhijie [1 ]
Rodewald, Lance E. [1 ]
Li, Xiaolei [3 ]
Wang, Dongyan [3 ]
Zhu, Hui [3 ]
Wang, Huaqing [1 ]
Feng, Zijian [7 ]
Xu, Wenbo [3 ]
Zhou, Jiushun [2 ]
Yin, Zundong [1 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, 27 Nan Wei Rd, Beijing 100050, Peoples R China
[2] Sichuan Prov Ctr Dis Control & Prevent, Chengdu, Peoples R China
[3] Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, Beijing, Peoples R China
[4] Liangshan Prefectural Ctr Dis Control & Prevent, Liangshan, Peoples R China
[5] Leibo Cty Ctr Dis Control & Prevent, Liangshan, Peoples R China
[6] Chinese Field Epidemiol Training Program, Beijing, Peoples R China
[7] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China
关键词
IMMUNOGENICITY; OUTBREAK; SAFETY;
D O I
10.1001/jamanetworkopen.2022.49710
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE The Sabin-strain inactivated poliovirus vaccine (IPV) may be a tool for polio outbreak response in certain situations. OBJECTIVE To investigate the response to a type 2 vaccine-derived poliovirus (VDPV2) outbreak. DESIGN, SETTING, AND PARTICIPANTS This case series was conducted in China after a VDPV2 was detected in stool specimens from a child with acute flaccid paralysis (AFP) in Sichuan Province in 2019, 3 years after the global withdrawal of live, attenuated type 2 oral poliovirus vaccine (OPV). Investigation followed National Health Commission and World Health Organization guidance and included searching hospitals for unreported AFP cases; testing stool specimens from the child, his contacts, and local children; enhanced environmental surveillance for VDPV2s in wastewater; and measuring vaccination coverage. Sabin-strain IPV campaigns were conducted in a wide geographic area. MAIN OUTCOMES AND MEASURES Any VDPV2 detection after completion of the supplementary immunization activities. RESULTS A 28-nucleotide-change VDPV2 was isolated from a young boy. Three VDPV2s were detected in healthy children; 2 were contacts of the original child, and none had paralysis. A search of 31 million hospital records found 10 unreported AFP cases; none were polio. No type 2 polioviruses were found in wastewater. Prior to the event, polio vaccine coverage was 65% among children younger than 5 years. Sabin-strain IPV campaigns reached more than 97% of targeted children, administering 1.4 million doses. No transmission source was identified. More than 1 year of enhanced poliovirus environmental and AFP surveillance detected no additional VDPVs. CONCLUSIONS AND RELEVANCE These findings suggest that the circulating VPDV2 outbreak in 2019 was associated with low vaccine coverage. An investigation discovered 3 infected but otherwise healthy children and no evidence of the virus in wastewater. Following Sabin-strain IPV-only campaigns expanding from county to prefecture, the poliovirus was not detected, and the outbreak response was considered by an expert panel and the World Health Organization to have been successful. This success suggests that the Sabin-strain IPV may be a useful tool for responding to circulating VDPV2 outbreaks when high-quality supplementary immunization activities can be conducted and carefully monitored in settings with good sanitation.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Implication of a High Risk for Type 2 Vaccine-Derived Poliovirus Emergence and Transmission After the Switch From Trivalent to Bivalent Oral Poliovirus Vaccine
    Yan, Dongmei
    Wang, Dongyan
    Zhang, Yong
    Li, Xiaolei
    Tang, Haishu
    Guan, Jing
    Song, Yang
    Zhu, Shuangli
    Xu, Wenbo
    JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (01): : 113 - 118
  • [42] Metagenomic sequencing, molecular characterization, and Bayesian phylogenetics of imported type 2 vaccine-derived poliovirus, Spain, 2021
    Fernandez-Garcia, Maria Dolores
    Faye, Martin
    Diez-Fuertes, Francisco
    Moreno-Docon, Antonio
    Chirlaque-Lopez, Maria Dolores
    Faye, Ousmane
    Cabrerizo, Maria
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [43] Epidemiology of type 2 vaccine-derived poliovirus outbreaks between 2016 and 2020 q
    Macklin, Grace R.
    Goel, Ajay K.
    Mach, Ondrej
    Tallis, Graham
    Ahmed, Jamal A.
    O'Reilly, Kathleen M.
    Grassly, Nicholas C.
    Diop, Ousmane M.
    VACCINE, 2023, 41 : A19 - A24
  • [44] Impact of exogenous sequences on the characteristics of an epidemic type 2 recombinant vaccine-derived poliovirus
    Riquet, Franck B.
    Blanchard, Claire
    Jegouic, Sophie
    Balanant, Jean
    Guillot, Sophie
    Vibet, Marie-Anne
    Rakoto-Andrianarivelo, Mala
    Delpeyroux, Francis
    JOURNAL OF VIROLOGY, 2008, 82 (17) : 8927 - 8932
  • [45] A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania
    Bandyopadhyay, Ananda S.
    Gast, Chris
    Brickley, Elizabeth B.
    Ruttimann, Ricardo
    Clemens, Ralf
    Oberste, M. Steven
    Weldon, William C.
    Ackerman, Margaret E.
    Connor, Ruth, I
    Wieland-Alter, Wendy F.
    Wright, Peter
    Usonis, Vytautas
    JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (01): : 119 - 127
  • [46] Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993
    Yang, CF
    Naguib, T
    Yang, SJ
    Nasr, E
    Jorba, J
    Ahmed, N
    Campagnoli, R
    van der Avoort, H
    Shimizu, H
    Yoneyama, T
    Miyamura, T
    Pallansch, M
    Kew, O
    JOURNAL OF VIROLOGY, 2003, 77 (15) : 8366 - 8377
  • [47] Quantitative Analysis of the Instant and Persistent Inhibition Effects of Maternal Poliovirus Antibodies on the Immune Response in a Phase IV Trial of a Sabin Strain-Based Inactivated Poliovirus Vaccine
    Yin, Qiongzhou
    Zheng, Yan
    Ying, Zhifang
    Li, Jingyu
    Jiang, Ya
    Bao, Wenmei
    Dou, Youjian
    Pu, Yi
    Lei, Jin
    Yang, Haitao
    Jiang, Ruiju
    Deng, Yan
    Zhao, Zhimei
    Pu, Jing
    Yang, Jing
    Li, Yadong
    Xu, Min
    Cai, Wei
    Che, Yanchun
    Shi, Li
    VACCINES, 2024, 12 (02)
  • [48] Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child
    Adu, Festus
    Iber, Jane
    Bukbuk, David
    Gumede, Nicksy
    Yang, Su-Ju
    Jorba, Jaume
    Campagnoli, Ray
    Sule, Waidi Folorunso
    Yang, Chen-Fu
    Burns, Cara
    Pallansch, Mark
    Harry, Tekena
    Kew, Olen
    VIRUS RESEARCH, 2007, 127 (01) : 17 - 25
  • [49] Response to back-to-back outbreaks of circulating vaccine-derived poliovirus type 2 in two nomadic pastoralist settlements in Oti Region, Ghana-2019
    Donne Kofi Ameme
    Yaw Ofori Yeboah
    John Kofi Odoom
    Senanu Kwesi Djokoto
    Ernest Akyereko
    Abdulaziz Mamudu
    Mukaila Diwura
    William Opare
    Patrick Avevor
    Stanley Diamenu
    Sally-Ann Ohene
    Ernest Kenu
    Franklin Asiedu-Bekoe
    Archives of Public Health, 81
  • [50] Isolation and characterization of circulating type 1 vaccine-derived poliovirus from sewage and stream waters in Hispaniola
    Vinjé, J
    Gregoricus, N
    Martin, J
    Gary, HE
    Cáceres, VM
    Venczel, L
    Macadam, A
    Dobbins, JG
    Burns, C
    Wait, D
    Ko, G
    Landaverde, M
    Kew, O
    Sobsey, MD
    JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (07): : 1168 - 1175